CONDITIONAL MUTAGENESIS TO STUDY C MYB FUNCTION
条件诱变研究 C MYB 功能
基本信息
- 批准号:6832196
- 负责人:
- 金额:$ 31.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-01-05 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Applicant's Abstract): It is clear that the c-myb protooncogene
plays a crucial role during hematopoiesis. In each hematopoietic lineage, c-myb
is abundantly expressed at the immature stages of differentiation and is turned
off at a relatively late time during the differentiation process. However,
virtually nothing is known about what role c-myb plays during hematopoietic
maturation, how that role is mediated or what the signaling pathways are that
regulate c-myb expression. Mice that are homozygous null at the c-myb locus die
at day fifteen during embryogenesis from a severe anemia. This finding
graphically demonstrated the significance of c-myb during hematopoiesis but has
precluded study of c-myb activity at the later stages of differentiation. The
lack of a tractable genetic system that will allow mutation of c-myb during the
later stages of hematopoietic maturation has been a major impediment to
understanding the role of c-myb during hematopoiesis. During T-cell development
in the thymus, c-myb is expressed in CD4+CD8+ double positive thymocytes but is
expressed at essentially undetectable levels in CD4+ and CD8+ single positive
cells. In the periphery, c-myb is not expressed in resting T-cells, but is
expressed in proliferating T-cells in late Gi/early S-phase of the cell cycle.
To begin to understand the role played by c-myb during T-cell development we
have produced mice that carry a c-myb allele targeted with loxP sites for
deletion by the Cre recombinase. By breeding these mice to available mouse
strains that direct Cre expression either to the early stages of T-cell
development in the thymus or in an inducible fashion, we will define the role
played by c-myb during T-cell development and the activation of effector
functions. In addition, these mice will be crucial to the field and will allow
one to begin to gain insight into c-myb function during hematopoiesis as well
as in other systems where c-myb function remains poorly understood. The goals
of this proposal are: 1) to determine at what stage c-myb expression is
essential for T-cell development and function, 2) to determine the consequences
of inappropriate c-myb expression to T-cell development and function and 3) to
identify c-myb functional domains required to drive T-cell development in the
thymus.
说明(申请人摘要):很明显,c-myb原癌基因
在造血过程中起着至关重要的作用在每个造血谱系中,c-myb
在分化的不成熟阶段大量表达,
在分化过程中相对较晚的时间关闭。然而,在这方面,
几乎没有人知道c-myb在造血过程中起什么作用。
成熟,这种作用是如何介导的,或者信号通路是什么,
调节c-myb表达。在c-myb基因座上纯合无效的小鼠死亡
在胚胎发生的第15天,由于严重贫血。这一发现
图中显示了c-myb在造血过程中的重要性,
排除了在分化后期对c-myb活性的研究。的
缺乏一个易于处理的遗传系统,将允许c-myb突变期间,
造血成熟的后期阶段一直是
了解c-myb在造血过程中的作用。在T细胞发育过程中
在胸腺中,c-myb在CD 4 + CD 8+双阳性胸腺细胞中表达,
在CD 4+和CD 8+单阳性中以基本上不可检测的水平表达
细胞在外周血中,c-myb在静息T细胞中不表达,但在静息T细胞中表达。
在细胞周期的G1晚期/S早期的增殖T细胞中表达。
为了开始了解c-myb在T细胞发育过程中的作用,
已经产生了携带c-myb等位基因的小鼠,该等位基因靶向loxP位点,
通过Cre重组酶进行缺失。通过将这些老鼠繁殖成可用的老鼠
将Cre表达引导至T细胞分化的早期阶段的菌株
在胸腺中或以诱导的方式发育,我们将定义
c-myb在T细胞发育和效应子激活中的作用
功能协调发展的此外,这些小鼠对该领域至关重要,并将允许
人们开始了解c-myb在造血过程中的功能
如在c-myb功能仍然知之甚少的其它系统中一样。的目标
该建议的主要内容是:1)确定c-myb表达在什么阶段
对T细胞发育和功能至关重要,2)确定后果
c-myb表达不当对T细胞发育和功能的影响; 3)
确定在T细胞中驱动T细胞发育所需的c-myb功能结构域,
胸腺
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy P. Bender其他文献
Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene
c-myb 转基因的晚期上调阻碍了小鼠红白血病细胞的分化
- DOI:
10.1128/mcb.10.2.705-710.1990 - 发表时间:
1990 - 期刊:
- 影响因子:5.3
- 作者:
Diana McCLINTON;Jeannine Stafford;Leslie;Brents;Timothy P. Bender;W. Michael;'. Kuehl - 通讯作者:
'. Kuehl
Expression of a transfected human c-myconcogene inhibits differentiation of a mouse erythroleukaemia cell line
转染的人 c-myc 癌基因的表达抑制小鼠红白血病细胞系的分化
- DOI:
10.1038/322748a0 - 发表时间:
1986-08-21 - 期刊:
- 影响因子:48.500
- 作者:
Ethan Dmitrovsky;W. Michael Kuehl;Gregory F. Hollis;Ilan R. Kirsch;Timothy P. Bender;Shoshana Segal - 通讯作者:
Shoshana Segal
Considerations for the physical vapor deposition of high molar mass organic compounds
- DOI:
10.1016/j.vacuum.2014.05.023 - 发表时间:
2014-11-01 - 期刊:
- 影响因子:
- 作者:
Jeffrey S. Castrucci;Jeremy D. Dang;Brett A. Kamino;Andrew Campbell;David Pitts;Zheng-Hong Lu;Timothy P. Bender - 通讯作者:
Timothy P. Bender
Redox behaviour of boron subphthalocyanine carbon nanotube composites
- DOI:
10.1016/j.nxmate.2024.100163 - 发表时间:
2024-04-01 - 期刊:
- 影响因子:
- 作者:
Raunaq Bagchi;Erika Remigio;Dian Yu;Nina F. Farac;Averey Kudlow;Jane Howe;Timothy P. Bender;Keryn Lian - 通讯作者:
Keryn Lian
Timothy P. Bender的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy P. Bender', 18)}}的其他基金
Signaling and Transcriptional Control of T Follicular Helper Cells and RBC Alloimmunization
滤泡辅助 T 细胞和红细胞同种免疫的信号传导和转录控制
- 批准号:
9753378 - 财政年份:2018
- 资助金额:
$ 31.16万 - 项目类别:
c-Myb in CD4 T cells is crucial for recall antibody responses
CD4 T 细胞中的 c-Myb 对于记忆抗体反应至关重要
- 批准号:
8820986 - 财政年份:2014
- 资助金额:
$ 31.16万 - 项目类别:
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesis
c-Myb 控制 B 淋巴细胞生成过程中的存活、增殖和分化
- 批准号:
8478146 - 财政年份:2011
- 资助金额:
$ 31.16万 - 项目类别:
c-Myb fusion proteins in Adenoid Cystic Carcinoma
腺样囊性癌中的 c-Myb 融合蛋白
- 批准号:
8303226 - 财政年份:2011
- 资助金额:
$ 31.16万 - 项目类别:
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesis
c-Myb 控制 B 淋巴细胞生成过程中的存活、增殖和分化
- 批准号:
8665994 - 财政年份:2011
- 资助金额:
$ 31.16万 - 项目类别:
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesis
c-Myb 控制 B 淋巴细胞生成过程中的存活、增殖和分化
- 批准号:
8162936 - 财政年份:2011
- 资助金额:
$ 31.16万 - 项目类别:
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesis
c-Myb 控制 B 淋巴细胞生成过程中的存活、增殖和分化
- 批准号:
8325520 - 财政年份:2011
- 资助金额:
$ 31.16万 - 项目类别:
c-Myb fusion proteins in Adenoid Cystic Carcinoma
腺样囊性癌中的 c-Myb 融合蛋白
- 批准号:
8174241 - 财政年份:2011
- 资助金额:
$ 31.16万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 31.16万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 31.16万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 31.16万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 31.16万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 31.16万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 31.16万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 31.16万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 31.16万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 31.16万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 31.16万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




